Bacterial infections are known to be one of the leading causes of deaths, worldwide. In fact, infections caused by bacteria are responsible for every one out of eight deaths, globally. This is because most pathogenic bacteria have developed resistance against the commonly prescribed therapies.
In addition, as per the Centers for Disease Control and Prevention (CDC), the annual healthcare cost associated with treatment of infections caused by six multi-drug resistant bacteria is estimated to be more than $4.6B in the US. Antibiotics (chemical substances derived from biological sources or produced chemically) are extensively being used for the prevention / treatment of various bacterial infections.
The continuous efforts of both industry and non-industry players as well as regulatory organizations, combined with the increasing patient population, are expected to be the key drivers for growth in the antibiotics market in the coming years.